What mediates the benefits associated with dipeptidyl peptidase-IV inhibition?
Ahrén
B
B
Department of Medicine, Lund University, Lund, Sweden. Bo.Ahren@med.lu.se
D000243:Adenosine Deaminase / Q000378:metabolism; D058892:Adenosine Deaminase Inhibitors; D000818:Animals; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D018819:Dipeptidyl Peptidase 4 / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D005749:Gastric Inhibitory Polypeptide / Q000378:metabolism; D005934:Glucagon / Q000819:agonists / Q000378:metabolism; D052216:Glucagon-Like Peptide 1; D006442:Glycated Hemoglobin / Q000378:metabolism; D006023:Glycoproteins / Q000037:antagonists & inhibitors* / Q000378:metabolism; D006031:Glycosylation / Q000187:drug effects; D006801:Humans; D008687:Metformin / Q000494:pharmacology; D051379:Mice; D009414:Nerve Growth Factors / Q000378:metabolism; D009479:Neuropeptides / Q000378:metabolism; D018377:Neurotransmitter Agents / Q000378:metabolism; D010446:Peptide Fragments / Q000819:agonists / Q000378:metabolism; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide; D011498:Protein Precursors / Q000819:agonists / Q000378:metabolism
D000243:Adenosine Deaminase; D058892:Adenosine Deaminase Inhibitors; D018819:Dipeptidyl Peptidase 4; D004791:Enzyme Inhibitors; D005749:Gastric Inhibitory Polypeptide; D005934:Glucagon; D052216:Glucagon-Like Peptide 1; D006442:Glycated Hemoglobin; D006023:Glycoproteins; D008687:Metformin; D009414:Nerve Growth Factors; D009479:Neuropeptides; D018377:Neurotransmitter Agents; D010446:Peptide Fragments; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide; D011498:Protein Precursors; C495401:ADCYAP1 protein, human; C495402:Adcyap1 protein, mouse; C042807:DPP4 protein, human